Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarwyn Value 21 Regulatory News (MVR2)

Share Price Information for Marwyn Value 21 (MVR2)

Share Price is delayed by 15 minutes
Get Live Data
105.00    0.00 (0.00%)
Bid:
80.00
Ask:
130.00
Spread: 50.00 (62.50%)
Market Cap: £59.36m
MVR2 Live PriceLast checked at - London Stock Exchange

Intraday Marwyn Value 21 Share Chart

Share Dealings

20 Oct 2025 07:00

RNS Number : 9017D
Marwyn Value Investors Limited
20 October 2025
Β 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO

Β 

LEI: 213800L5751QTTVEA774

20 October 2025

MARWYN VALUE INVESTORS LIMITED (THE "COMPANY")

SHARE DEALINGS

The Company announces that it has been notified that on 16 October 2025, James Corsellis, Chief Investment Officer of Marwyn Investment Management LLP ("MIM"), the manager of the Company, purchased 54,000 Ordinary Shares in the Company at a price of 134.3459 pence per share and Marwyn Capital Management Limited ("MCML"), a company owned by James Corsellis, purchased 551,953 Ordinary Shares in the Company at a price of 134.3459 pence per share. The aggregate holding of Ordinary Shares by James and MCML is now 6,971,633 shares, representing approximately 12.33% of the Company's voting rights.

It is expected that 37,761 of the Ordinary Shares acquired by MCML will subsequently be acquired by Marwyn employees, following which, the aggregate holding of Ordinary Shares by James and MCML will be 6,933,872 shares, representing approximately 12.26% of the Company's voting rights.

Also on 16 October, Antoinette Vanderpuije, partner of MIM, purchased 5,547 Ordinary Shares at a price of 134.3459 pence per share. Antoinette now holds 231,259 Ordinary Shares, representing approximately 0.41% of the Company's voting rights.

On 17 October 2025, Tom Basset, partner of MIM, purchased 3,692 Ordinary Shares at a price of 135.4 pence per share. Tom now holds 52,404 Ordinary Shares, representing approximately 0.09% of the Company's voting rights.

Whilst none of James Corsellis, Antoinette Vanderpuije, Tom Basset or MCML are Persons Discharging Managerial Responsibility ("PDMR") within the meaning of the UK version of Regulation (EU) 596/2014, as incorporated in the UK by virtue of the European Union (Withdrawal) Act 2018, as amended in relation to the Company, they have voluntarily disclosed the information above to the Company, and the Company is voluntarily disclosing the information above to the market, as if they were PDMRs in relation to the Company.

Β 

Company enquiries:

Marwyn Value Investors Limited

Scott Danks

scottdanks@marwyn.com

Β 

Company Secretary - Palmer Fund Services (Jersey) Limited

marwyn@palmerfs.com

1 Grenville Street

St Helier

Jersey JE2 4UF

Β 

Investor Relations - KK Advisory Limited

Kam Bansil

020 7039 1901

Β 

PR Adviser - FGS GlobalRollo Head 07768 994987Chris Sibbald 07855 955531

Β 

Corporate Broker - Panmure Liberum Limited

Chris Clarke

0203 100 2200

Β 

Shares in the Company are not designed or intended for retail investors. Marwyn Investment Management LLP, the Manager, does not promote shares in the Company to retail investors and they should not be offered to retail investors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHFLFESIVLALIE
Date   Source Headline
2nd Jun 202610:10 amRNSNet Asset Value - 2021 Realisation Shares
26th May 202611:00 amRNSNet Asset Values
18th May 202611:00 amRNSNet Asset Values
11th May 202611:00 amRNSNet Asset Values
5th May 202610:21 amRNSNet Asset Value - 2021 Realisation Shares
20th Apr 202611:00 amRNSNet Asset Values
16th Apr 202611:00 amRNSNet Asset Values
15th Apr 202610:10 amRNSNet Asset Value - 2021 Realisation Shares
30th Mar 202611:00 amRNSNet Asset Values
23rd Mar 202611:00 amRNSNet Asset Values
16th Mar 202611:00 amRNSNet Asset Values
9th Mar 202611:00 amRNSNet Asset Values
3rd Mar 202610:10 amRNSNet Asset Value - 2021 Realisation Shares
23rd Feb 202611:00 amRNSNet Asset Values
16th Feb 202611:00 amRNSNet Asset Values
9th Feb 202611:00 amRNSNet Asset Values
3rd Feb 202610:10 amRNSNet Asset Value - 2021 Realisation Shares
26th Jan 202611:00 amRNSNet Asset Values
19th Jan 202611:00 amRNSNet Asset Values
16th Jan 202611:00 amRNSNet Asset Values
15th Jan 202610:10 amRNSNet Asset Value - 2021 Realisation Shares
22nd Dec 202511:00 amRNSNet Asset Values
15th Dec 202511:00 amRNSNet Asset Values
10th Dec 202512:14 pmRNSResult of Annual General Meeting
8th Dec 202511:00 amRNSNet Asset Values
2nd Dec 20251:10 pmRNSNet Asset Value - 2021 Realisation Shares
24th Nov 202511:00 amRNSNet Asset Values
17th Nov 202511:00 amRNSNet Asset Values
10th Nov 202511:00 amRNSNet Asset Values
4th Nov 202510:10 amRNSNet Asset Value - 2021 Realisation Shares
3rd Nov 20257:00 amRNSNotice of Annual General Meeting
27th Oct 202511:00 amRNSNet Asset Values
20th Oct 202511:00 amRNSNet Asset Values
20th Oct 20257:00 amRNSShare Dealings
14th Oct 202511:00 amRNSNet Asset Values
13th Oct 20253:10 pmRNSNet Asset Value - 2021 Realisation Shares
30th Sep 20257:00 amRNSUnaudited Interim Results 2025
22nd Sep 202511:00 amRNSNet Asset Values
15th Sep 202511:00 amRNSNet Asset Values
8th Sep 202511:00 amRNSNet Asset Values
2nd Sep 202510:10 amRNSNet Asset Value - 2021 Realisation Shares
18th Aug 202511:00 amRNSNet Asset Values
11th Aug 202511:00 amRNSNet Asset Values
4th Aug 202510:10 amRNSNet Asset Value - 2021 Realisation Shares
21st Jul 202511:00 amRNSNet Asset Values
15th Jul 202511:00 amRNSNet Asset Values
14th Jul 202512:10 pmRNSNet Asset Value - 2021 Realisation Shares
23rd Jun 202511:00 amRNSNet Asset Values
16th Jun 202511:00 amRNSNet Asset Values
9th Jun 202511:00 amRNSNet Asset Values

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.